泰宗 4169
Listed · Biotechnology and medical care116.5▼-4 (-3.32%)After close
- Prev close
- 120.5
- Volume (shares)
- 119,935
- Data time
- 2026-11-11 13:30:00
- Open
- 120.50
- High
- 121.00
- Low
- 116.00
- Prev close
- 120.50
- Volume (lots)
- 120
- Turnover
- 0.14 億
- P/E
- —
- Cash yield
- 0.27%
Financial trends
Loading…
Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.
Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC
Loading…
Figures are shown as announced, with no scoring or rating.
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 47.11% | 44.65% | 44.20% | 45.19% | — | — | — | — |
| Operating margin | -5.81% | -16.09% | -3.78% | 3.61% | — | — | — | — |
| Net margin | -4.68% | -15.24% | -2.53% | 4.48% | — | — | — | — |
| ROE (TTM) | -2.09% | — | 1.81% | — | 2.57% | 1.99% | 2.51% | 2.33% |
| ROA (TTM) | -1.90% | — | 1.61% | — | 2.17% | 1.68% | 1.88% | 1.70% |
| EPS, quarter (TWD) | -0.10 | -0.45 | -0.08 | 0.13 | — | — | — | — |
| EPS, TTM (TWD) | -0.50 | — | 0.32 | — | 0.46 | 0.36 | 0.34 | 0.35 |
| Month | Revenue | MoM | YoY | YTD | YTD YoY |
|---|---|---|---|---|---|
| 2026-09 | 0.6 | 0.33% | -2.08% | 5.4 | 5.84% |
| 2026-08 | 0.6 | 0.66% | 21.80% | 4.8 | 6.97% |
| 2026-07 | 0.6 | -4.65% | 6.66% | 4.2 | 5.05% |
| 2026-06 | 0.6 | 13.33% | 4.01% | 3.5 | 4.78% |
| 2026-05 | 0.6 | -3.34% | -17.16% | 2.9 | 4.95% |
| 2026-04 | 0.6 | -4.27% | 15.40% | 2.3 | 12.34% |
| 2026-03 | 0.6 | 34.75% | 9.10% | 1.7 | 11.33% |
| 2026-02 | 0.5 | -29.75% | -17.56% | 1.1 | 12.61% |
| 2026-01 | 0.7 | 17.96% | 51.58% | 0.7 | 51.58% |
| 2025-12 | 0.6 | -12.71% | -20.42% | 6.9 | 2.85% |
| 2025-11 | 0.6 | 12.64% | 15.42% | 6.3 | 5.56% |
| 2025-10 | 0.6 | -11.66% | 18.61% | 5.7 | 4.56% |
Revenue in NT$100M; 12 months per page.
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.8 | 1.7 | 1.7 | 1.7 | — | — | — | — |
| Cost of revenue | 1.0 | 1.0 | 1.0 | 0.9 | — | — | — | — |
| Gross profit | 0.9 | 0.8 | 0.8 | 0.8 | — | — | — | — |
| Operating expenses | 1.0 | 1.1 | 0.8 | 0.7 | — | — | — | — |
| Operating income | -0.1 | -0.3 | -0.1 | 0.1 | — | — | — | — |
| Non-operating items | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — |
| Pre-tax income | -0.1 | -0.3 | -0.0 | 0.1 | — | — | — | — |
| Income tax | -0.0 | 0.0 | -0.0 | 0.0 | — | — | — | — |
| Continuing operations | -0.1 | -0.3 | -0.0 | 0.1 | — | — | — | — |
| Net income | -0.1 | -0.3 | -0.0 | 0.1 | — | — | — | — |
| Net income to parent | -0.1 | -0.3 | -0.0 | 0.1 | — | — | — | — |
| Other comprehensive income | -0.4 | -0.0 | -0.0 | -0.0 | — | — | — | — |
| Total comprehensive income | -0.5 | -0.3 | -0.1 | 0.1 | — | — | — | — |
| EPS (TWD) | -0.10 | -0.45 | -0.08 | 0.13 | — | — | — | — |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|
| Current assets | 15.6 | 9.3 | 8.6 | 8.2 | 8.5 | 8.1 | 9.2 | 9.8 |
| Non-current assets | 5.4 | 3.4 | 3.5 | 3.5 | 3.6 | 3.7 | 3.5 | 3.4 |
| Total assets | 21.0 | 12.7 | 12.0 | 11.8 | 12.1 | 11.8 | 12.7 | 13.2 |
| Current liabilities | 1.3 | 1.4 | 1.1 | 0.8 | 1.2 | 0.8 | 1.5 | 2.0 |
| Non-current liabilities | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.7 | 0.7 |
| Total liabilities | 1.5 | 1.6 | 1.5 | 1.2 | 1.6 | 1.2 | 2.2 | 2.7 |
| Share capital | 6.6 | 6.6 | 5.9 | 5.9 | 5.9 | 5.9 | 5.9 | 5.9 |
| Capital surplus | 13.3 | 4.5 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 4.2 |
| Retained earnings | -0.0 | 0.0 | 0.5 | 0.6 | 0.5 | 0.5 | 0.4 | 0.5 |
| Other equity | -0.4 | -0.0 | -0.0 | -0.0 | 0.0 | -0.0 | -0.0 | -0.0 |
| Equity to parent | 19.5 | 11.1 | 10.6 | 10.6 | 10.5 | 10.6 | 10.5 | 10.6 |
| Total equity | 19.5 | 11.1 | 10.6 | 10.6 | 10.5 | 10.6 | 10.5 | 10.6 |
| Book value per share (TWD) | 29.42 | 18.57 | 17.87 | 17.96 | 17.86 | 17.94 | 17.75 | 17.87 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.4 | -0.1 | 0.3 | 0.1 | — | — | — | — |
| Investing cash flow | -2.4 | -0.0 | 0.0 | -0.0 | — | — | — | — |
| Financing cash flow | 8.9 | 0.5 | -0.0 | -0.2 | — | — | — | — |
| FX effect | -0.0 | -0.0 | -0.0 | -0.0 | — | — | — | — |
| Net change in cash | 6.0 | 0.5 | 0.3 | -0.1 | — | — | — | — |
| Cash, beginning | 2.5 | 2.5 | 2.3 | 2.3 | 2.3 | 5.0 | 5.0 | 0.9 |
| Cash, ending | 9.0 | 2.9 | 2.5 | 2.2 | 2.3 | 2.3 | 3.7 | 5.0 |
Amounts in NT$100M (per-share items in NT$).
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 1,168.07% | — | — | — | — | — | — | — |
| Debt ratio | 7.12% | 12.61% | 12.36% | 10.04% | 13.13% | 10.43% | 17.46% | 20.25% |
| Equity ratio | 92.88% | 87.39% | 87.64% | 89.96% | 86.87% | 89.57% | 82.54% | 79.75% |
| Equity multiplier | 1.08 | 1.14 | 1.14 | 1.11 | 1.15 | 1.12 | 1.21 | 1.25 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|
| Asset turnover (TTM revenue / avg. assets) | 0.42 | — | 0.55 | — | 0.65 | 0.65 | 0.81 | 0.90 |
| Equity turnover | 0.47 | — | 0.65 | — | 0.84 | 0.84 | 1.06 | 1.23 |
Source: MOPS. For reference only; not investment advice.